Dr. Thompson is Assistant Professor of Medicine at the University of California, Davis, School of Medicine with a joint appointment in the Departments of Medical Microbiology and Immunology, and Internal Medicine, Division of Infectious Diseases. Dr. Thompson specializes in the care of patients with invasive fungal infections and has research interest in fungal diagnostics and host immunogenetics. His current research focuses on the host-pathogen interaction of humans and both Coccidioides spp. (the agent of “Valley Fever”), and Cryptococcus spp.
Dr. Thompson has substantial expertise in the care of patients with fungal diseases and serves on the Mycoses Study Group Education Committee which is responsible for the dissemination of materials and knowledge to clinicians across the country to improve the care of patients with fungal infections. He additionally was recently appointed to the Coccidioidomycosis Study Group and the Infectious Diseases Society of America (IDSA) Journal Club providing editorials in the monthly internationally disseminated IDSA Newsletter.
Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR III. Invasive Aspergillosis Following H1N1 Influenza. Emerging Infectious Diseases. 2010; Jun; 16(6):971-3. PMID: 20507748
Thompson GR III, Patel PK, Erlandsen J, Redding SW, Patterson TF. Oropharyngeal Candidiasis in the Era of Highly Active Antiretroviral Therapy. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2010; Apr: 109(4):488-95. PMID: 20156694
Cadena J, Thompson GR III, Ho T, Medina E, Hughes D, Patterson TF. Immune Reconstitution Inflammatory Syndrome (IRIS) Following Cessation of the TNF-α Blocker Adalimumab in Cryptococcal Pneumonia. Diagnostic Microbiology and Infectious Diseases. 2009; July; 64(3):327–330. PMID: 19501793
Thompson GR III, Wiederhold NP, Sutton DA, Fothergill AW, PattersonTF. In Vitro Activity of Isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces, and Pichia Species. The Journal of Antimicrobial Chemotherapy. 2009; Jul; 64(1):79-83. PMID: 19406849
Thompson GR III, Rinaldi MG, Pennick G, Dorsey SA, Patterson TF, Lewis JS. Posaconazole Therapeutic Drug Monitoring (TDM) – A Reference Laboratory Experience. Antimicrobial Agents and Chemotherapy. 2009; May; 53(5):2223-4. PMID: 19258264
Thompson GR III, Lewis JS II. Pharmacology and clinical use of voriconazole. Expert Opinion on Drug Metabolism and Toxicology. 2009;6(1):83-94. PMID: 19947892
Thompson GR III, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF. Antifungal Susceptibility Among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 2009; Jan: 53(1):309-311. PMID: 18955539
Thompson GR III, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS 2nd, Patterson TF. Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata. Antimicrobial Agents and Chemotherapy. 2008; Oct;52(10):3783-3785. PMID: 18676885
Thompson GR III, Patterson TF. Pulmonary Aspergillosis. Seminars in Respiratory and Critical Care Medicine. 2008;29(2):103-10. PMID: 18365992
Thompson GR III, LaValle CE, Everett ED. Unusual Manifestations of Histoplasmosis. Diagnostic Microbiology and Infectious Disease. 2004; 50(1):33-41. PMID: 15380276